title,summary,source,time_published,topics,overall_sentiment_label,overall_sentiment_score,ticker
"JNJ Tops Q1 Earnings, Ups '25 Sales View to Include Intra-Cellular Deal",J&J beats first-quarter earnings and sales estimates. It raises sales guidance for 2025 to reflect the addition of Caplyta from the Intra-Cellular acquisition.,Zacks Commentary,20250415T151400,"[{'topic': 'Earnings', 'relevance_score': '0.999594'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",Neutral,0.076771,JNJ
Import Prices Turn Negative for First Time Since September,"New economic data is out this morning, some of it reflecting conditions prior to our current tariff realities. We also see Q1 earnings results continue to ramp up, but we won't have the spigots open completely til next week.",Zacks Commentary,20250415T150400,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",Neutral,0.095054,JNJ
"Import Prices, Empire State Come In Mild; Q1 Earnings Beats Abound","Pre-markets are down somewhat, following yesterday's +3/4-percent gain on the Dow and the S&P 500, +2/3-percent gain for the Nasdaq.",Zacks Commentary,20250415T141900,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.986413'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",Neutral,0.090163,JNJ
"Compared to Estimates, Johnson & Johnson  ( JNJ )  Q1 Earnings: A Look at Key Metrics","While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",Zacks Commentary,20250415T133005,"[{'topic': 'Earnings', 'relevance_score': '0.929393'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",Somewhat-Bullish,0.252836,JNJ
"Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit - Johnson & Johnson  ( NYSE:JNJ ) ","Q1 adjusted EPS of $2.77 beat estimates; cancer drug Darzalex sales jumped 20.3% to $3.24 billion. 2025 sales forecast raised to up to $91.8 billion; dividend hiked 4.8% to $1.30 per share, payable June 10. China's new tariffs just reignited the same market patterns that led to triple- and ...",Benzinga,20250415T130910,"[{'topic': 'Earnings', 'relevance_score': '0.316726'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",Somewhat-Bullish,0.172939,JNJ
Johnson & Johnson  ( JNJ )  Q1 Earnings and Revenues Beat Estimates,"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 7.78% and 1.26%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",Zacks Commentary,20250415T113502,"[{'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",Neutral,0.144269,JNJ
Can ISRG Stock Revive its Growth Momentum After the Sudden Slide?,Intuitive Surgical has maintained an uptrend since late 2022 with price correcting to 200-DMA a few times and again continuing the uptrend. Will it repeat?,Zacks Commentary,20250415T112200,"[{'topic': 'Earnings', 'relevance_score': '0.967645'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999365'}]",Somewhat-Bullish,0.163512,JNJ
Genmab Announces Net Sales of DARZALEXÂ®  ( daratumumab )  for First Quarter of 2025,Company Announcement ...,GlobeNewswire,20250415T102200,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",Neutral,0.014436,JNJ
"US Stock Futures Waver After Two-Day Rally: Trump's Tariff Moves Could End A 3-Year 'Rolling Recession,' Says Expert - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",U.S. stock futures were volatile on Tuesday following a two-day advance. Futures of major benchmark indices were mixed in premarket. Donald Trump hinted at helping the car companies while talking to reporters in his Oval Office on Monday.,Benzinga,20250415T100831,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.99676'}, {'topic': 'Earnings', 'relevance_score': '0.997874'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",Neutral,0.146726,JNJ
"Citigroup, Bank Of America And 3 Stocks To Watch Heading Into Tuesday - Citigroup  ( NYSE:C ) , Bank of America  ( NYSE:BAC ) ","With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Citigroup Inc. C to report quarterly earnings at $1.85 per share on revenue of $21.29 billion before the opening bell, according to data from ...",Benzinga,20250415T083932,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Earnings', 'relevance_score': '0.997874'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",Somewhat-Bullish,0.267546,JNJ
Johnson & Johnson Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Johnson & Johnson  ( NYSE:JNJ ) ,"Johnson & Johnson JNJ will release earnings results for the first quarter, before the opening bell on Tuesday, April 15. Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings at $2.58 per share, down from $2.71 per share in the year-ago period.",Benzinga,20250415T073301,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",Somewhat-Bullish,0.196476,JNJ
"US Stock Futures Slip As Investors Brace Themselves For Netflix, AmEx Earnings This Week - Nikkei Up On Strong Sentiment - Bank of America  ( NYSE:BAC ) , American Express  ( NYSE:AXP ) ","After two days of back-to-back gains in the spot market, U.S. stock futures had a choppy session Monday night as investors await earnings reports from multiple prominent companies.",Benzinga,20250415T020837,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",Neutral,0.138995,JNJ
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results,"- Appointed John H. Johnson as Executive Chairman. Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer. and Reena Thomas Colacot as Vice President and Head of Quality ...",GlobeNewswire,20250414T215000,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",Somewhat-Bullish,0.155646,JNJ
"JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview","JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp have been highlighted in this Earnings Preview article.",Zacks Commentary,20250414T072200,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",Neutral,0.038431,JNJ
Novartis  ( NVS )  Surges 4.0%: Is This an Indication of Further Gains?,Novartis (NVS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.,Zacks Commentary,20250414T063000,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",Somewhat-Bullish,0.217841,JNJ
"Jim Cramer's week ahead: Earnings from Goldman Sachs, Johnson & Johnson and Netflix",CNBC's Jim Cramer on Friday told investors which market-moving events to follow next week.,CNBC,20250411T225659,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.94762'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}]",Neutral,0.102159,JNJ
Are Tariff Worries Affecting the Earnings Outlook?,There are many valid reasons for the market to remain focused on tariffs since so much is happening in the broader economy. But how are they affecting the earnings outlook for the coming periods?,Zacks Commentary,20250411T221700,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",Neutral,0.031238,JNJ
"Buy, Sell or Hold J&J Stock? Key Tips Ahead of Q1 Earnings",JNJ's Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Tremfya. We do not expect any improvement in MedTech sales.,Zacks Commentary,20250411T153200,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.998287'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",Somewhat-Bullish,0.169194,JNJ
"Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties - Novartis  ( NYSE:NVS ) ","Novartis will invest $23 billion over five years to expand U.S. manufacturing and research. The company will build facilities in the U.S., including a $1.1 billion R&D hub in San Diego. Feel unsure about the market's next move?",Benzinga,20250411T133646,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",Somewhat-Bullish,0.279289,JNJ
Is First Trust Dow 30 Equal Weight ETF  ( EDOW )  a Strong ETF Right Now?,Smart Beta ETF report for ...,Zacks Commentary,20250411T102002,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999994'}]",Somewhat-Bullish,0.246278,JNJ
2 Top Dividend Stocks to Buy Right Now,Microsoft ( NASDAQ: MSFT ) and Johnson & Johnson ( NYSE: JNJ ) are leading companies in their respective industries. They both have impressive track records and have made their long-term shareholders significantly richer.Some might worry that it's too late to invest in these blue chip companies.,Motley Fool,20250411T082500,"[{'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",Neutral,0.128316,JNJ
"Johnson & Johnson, Protagonist Tout Positive Results For Psoriasis Oral Pill Study - Protagonist Therapeutics  ( NASDAQ:PTGX ) , Johnson & Johnson  ( NYSE:JNJ ) ","84.1% of adolescents on icotrokinra achieved clear/almost clear skin at Week 16 vs. 27.3% on placebo in Phase 3 PsO study. By Week 24, 75% of adolescents on icotrokinra had completely clear skin ( IGA 0 ) , with no new safety issues reported.",Benzinga,20250410T142051,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",Somewhat-Bullish,0.17927,JNJ
"Alphabet To $185? Here Are 10 Top Analyst Forecasts For Thursday - BorgWarner  ( NYSE:BWA ) , Amazon.com  ( NASDAQ:AMZN ) ","Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Fargo raised Toast, Inc. TOST price target from $30 to $39.",Benzinga,20250410T132412,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",Somewhat-Bullish,0.182771,JNJ
Seeking Clues to Johnson & Johnson  ( JNJ )  Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics,"Evaluate the expected performance of Johnson & Johnson (JNJ) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",Zacks Commentary,20250410T131512,"[{'topic': 'Earnings', 'relevance_score': '0.967321'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",Somewhat-Bullish,0.157074,JNJ
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",Zacks Commentary,20250410T130015,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",Somewhat-Bullish,0.235685,JNJ
Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?,Sector ETF report for ...,Zacks Commentary,20250410T102006,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",Somewhat-Bullish,0.268184,JNJ
"If Your Portfolio Is Down on the Tariff News, Check Out This Little-Known High-Yield Dividend Stock",Investors are dumping growth stocks right now as new tariff policies rock the markets.,Motley Fool,20250410T100500,"[{'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",Somewhat-Bullish,0.224358,JNJ
Stock Market Sell-Off Shopping Spree: 3 Top Dividend Stocks I Just Bought to Boost My Passive Income,"Stock market sell-offs like the one we're currently experiencing are challenging periods for investors. However, with every challenge comes an opportunity to improve. For me, sell-offs are an opportunity to buy high-quality dividend stocks at lower prices, which enables me to lock in higher ...",Motley Fool,20250410T091700,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.99977'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}]",Somewhat-Bullish,0.256505,JNJ
"The Dow Crashed 4,260 Points in 3 Days: Here Are 3 Dow Stocks That Make for No-Brainer Buys Right Now",Three of the Dow's 30 components make for sensational buys amid a historic sell-off.,Motley Fool,20250410T075100,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999696'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}]",Neutral,0.13291,JNJ
Pharmaceutical stocks fall as Trump doubles down on tariffs threat,"Trump on Tuesday said his administration will be announcing a ""major"" tariff on pharmaceuticals ""very shortly."" ...",CNBC,20250409T155136,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}]",Neutral,-0.074324,JNJ
This Johnson & Johnson Analyst Turns Bullish On Shifting Focus From Stelara Concerns To Innovative Medicine - Johnson & Johnson  ( NYSE:JNJ ) ,"Johnson & Johnson's Innovative Medicine contributes disproportionately higher profits. The concerns around the Stelara exclusivity appear overblown. With stocks plunging, steady income is key. Tim Melvin & Ryan Faloona reveal dividend stocks and deep-value plays on April 8. Reserve your spot now.",Benzinga,20250409T152820,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",Somewhat-Bullish,0.151718,JNJ
5 Top Growth Stocks to Buy in the Stock Market Sell-Off,"Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right now -- quite the contrary. History tells us that equities tend to experience strong runs following downturns, so it's worth putting ...",Motley Fool,20250409T140000,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",Bullish,0.391155,JNJ
Tesla Underdelivers,And we take a look at Texas Instruments and Taiwan Semiconductor.,Motley Fool,20250409T134600,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}]",Neutral,0.106708,JNJ
"Amazon.com To $255? Here Are 10 Top Analyst Forecasts For Wednesday - Americold Realty Trust  ( NYSE:COLD ) , Amazon.com  ( NASDAQ:AMZN ) ","Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays cut Americold Realty Trust, Inc. COLD price target from $26 to $21.",Benzinga,20250409T124706,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.752319'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",Somewhat-Bullish,0.202773,JNJ
"This Apple Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday - Apple  ( NASDAQ:AAPL ) , Bath & Body Works  ( NYSE:BBWI ) ","Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Seaport Global analyst David Joyce upgraded the rating for Sirius XM Holdings Inc.",Benzinga,20250409T121042,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",Somewhat-Bullish,0.30954,JNJ
Is First Trust Capital Strength ETF  ( FTCS )  a Strong ETF Right Now?,Smart Beta ETF report for ...,Zacks Commentary,20250409T102004,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999892'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",Somewhat-Bullish,0.263249,JNJ
ValoTx Appoints Marcella Origgi from Johnson & Johnson Innovation as CEO,"HELSINKI and NAPLES, Italy, April 09, 2025 ( GLOBE NEWSWIRE ) -- Valo Therapeutics Oy ( ValoTx ) , an immunotherapy company developing novel, adaptable treatments for cancer, today announced the appointment of Marcella Origgi as its Chief Executive Officer ( CEO ) of its Helsinki headquarters ...",Benzinga,20250409T070000,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",Somewhat-Bullish,0.314162,JNJ
Johnson & Johnson  ( JNJ )  Stock Moves -0.52%: What You Should Know,"In the latest trading session, Johnson & Johnson (JNJ) closed at $149.83, marking a -0.52% move from the previous day.",Zacks Commentary,20250408T214516,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.99246'}]",Neutral,0.134269,JNJ
Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst - Legend Biotech  ( NASDAQ:LEGN ) ,"Legend Biotech has no tariff exposure and manufactures Carvykti entirely in the U.S. for both U.S. and EU markets. HC Wainwright maintains a $75 target, citing Carvykti's strong efficacy and positioning in earlier lines of multiple myeloma treatment.",Benzinga,20250408T185930,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",Somewhat-Bullish,0.199325,JNJ
Johnson & Johnson's New 'Compelling Data' Shows Sustained Symptom Improvement In Muscular Disease Patients - Johnson & Johnson  ( NYSE:JNJ ) ,Nipocalimab led to sustained MG-ADL and QMG improvements over 84 weeks with long-term IgG reduction in gMG patients. 45% of patients cut steroid use by over 50%; mean prednisone dose dropped from 23 mg to 10 mg in the OLE phase. Feel unsure about the market's next move?,Benzinga,20250408T182632,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",Somewhat-Bullish,0.196472,JNJ
Johnson & Johnson  ( JNJ )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?,Johnson & Johnson (JNJ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,Zacks Commentary,20250408T140009,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",Somewhat-Bullish,0.182456,JNJ
Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?,Sector ETF report for ...,Zacks Commentary,20250408T102007,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",Somewhat-Bullish,0.224337,JNJ
Is the Vanguard Value ETF the Best Ultra-Low-Cost Fund for Generating Passive Income?,"Collecting passive income from stocks is a simple and effective way to participate in the market without having the return based solely on stock prices going up.Exchange-traded funds ( ETFs ) that invest in dividend stocks provide the added benefit of diversification, making them solid options ...",Motley Fool,20250408T094000,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",Somewhat-Bullish,0.281377,JNJ
Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development,"Steen Lisby, M.D., D.MSc. joins as Chief Medical Officer Jesper ValbjÃ¸rn, M.Sc. joins as Senior Vice President CMC Ongoing team expansion at Myricx Bio's new facilities in London's Canary Wharf biotech hub following 2024 Â£90 million ( $114 million ) series A financing",Benzinga,20250408T091636,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",Somewhat-Bullish,0.190547,JNJ
"Why Health Care Select Sector SPDR Fund  ( XLV )  Is Moving - SPDR Select Sector Fund - Health Care  ( ARCA:XLV ) , Pfizer  ( NYSE:PFE ) , UnitedHealth Group  ( NYSE:UNH ) ","Shares of the Health Care Select Sector SPDR Fund are trading lower by 8.6% over the past week. Tariff announcements from President Donald Trump last week spooked investors and have dragged major sectors. With stocks plunging, steady income is key.",Benzinga,20250407T182127,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",Neutral,0.06834,JNJ
5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025,"New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position GILD, BMRN, KRYS, ADMA and FOLD well in this volatile sector.",Zacks Commentary,20250407T172200,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '0.977154'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.495866'}]",Somewhat-Bullish,0.25719,JNJ
All the Stocks Warren Buffett Bought in the Last 2 Recessions: Are They Smart Picks Now?,"The U.S. economy is ""perilously close to slipping into recession"" because of President Donald Trump's tariffs, according to JPMorgan Chase chief economist Michael Feroli. Should investors worry? I can think of one who won't.",Motley Fool,20250406T084600,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",Neutral,0.002473,JNJ
President Trump's Tariffs Have Arrived. 3 Things to Do to Protect Your Portfolio.,"The idea of an import tax started weighing on investor sentiment in March, when President Trump laid out his initial plan to target Canada, Mexico, and China. Stocks tumbled, with the S&P 500 ( SNPINDEX: ^GSPC ) and Nasdaq Composite ( NASDAQINDEX: ^IXIC ) both temporarily slipping into correction ...",Motley Fool,20250405T074000,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",Neutral,0.147721,JNJ
"Sit Out Market Drama With These 3 Dividend Funds - Chevron  ( NYSE:CVX ) , iShares Select Dividend ETF  ( NASDAQ:DVY ) ","The new trade war precipitated by President Donald Trump's tariffs has turned investors against companies heavily involved in the import-export market. Instead, companies with stable revenue, low valuations and little exposure to trade are rising. Especially ones that offer nice dividends.",Benzinga,20250404T195239,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999986'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",Somewhat-Bullish,0.249446,JNJ
Johnson & Johnson's Tremfya Shows Efficacy In Late-Stage Psoriatic Arthritis Study - Johnson & Johnson  ( NYSE:JNJ ) ,"Tremfya met its primary and major secondary endpoints in the Phase 3b study, showing reduced symptoms and structural damage. Tremfya-treated patients had significantly less structural damage progression at 24 weeks versus placebo. With stocks plunging, steady income is key.",Benzinga,20250404T183530,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}]",Neutral,0.083976,JNJ
The Zacks Analyst Blog Highlights Johnson & Johnson and Pfizer,Johnson & Johnson and Pfizer are part of the Zacks top Analyst ...,Zacks Commentary,20250404T130400,"[{'topic': 'Earnings', 'relevance_score': '0.99393'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",Somewhat-Bullish,0.175722,JNJ
"Trump's Tariff Exemptions Include Semiconductors, Pharmaceuticals, Oil And More - Broadcom  ( NASDAQ:AVGO ) ","Semiconductors, lumber, gold and oil are among the imports exempt from Trump's retaliatory tariffs. Pharmaceutical stocks are defying Thursday's broad market drop with shares of AbbVie and Johnson & Johnson both green.",Benzinga,20250403T163042,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",Neutral,0.116352,JNJ
JNJ vs. PFE: Which Drug Giant is a Better Buy Now?,Both JNJ & PFE expect their sales and profits to improve in 2025.,Zacks Commentary,20250403T135900,"[{'topic': 'Earnings', 'relevance_score': '0.99393'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",Somewhat-Bullish,0.169279,JNJ
Worried About the Economy? 2 No-Brainer Buys to Shield Your Portfolio.,"The Nasdaq Composite ( NASDAQINDEX: ^IXIC ) and the S&P 500 ( SNPINDEX: ^GSPC ) sank, shifting in and out of correction territory in the first quarter of the year for one big reason: investors have been worried about the economy.",Motley Fool,20250402T221500,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}, {'topic': 'Earnings', 'relevance_score': '0.99994'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",Somewhat-Bullish,0.259184,JNJ
Johnson & Johnson  ( JNJ )  Exceeds Market Returns: Some Facts to Consider,"The latest trading day saw Johnson & Johnson (JNJ) settling at $155.36, representing a +1.38% change from its previous close.",Zacks Commentary,20250402T214515,"[{'topic': 'Earnings', 'relevance_score': '0.986564'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",Somewhat-Bullish,0.195116,JNJ
NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results,"Conference call and webcast scheduled for April 3, 2025 at 8:00 A.M. EDT / 2:00 P.M. CEST ...",GlobeNewswire,20250402T201500,"[{'topic': 'Earnings', 'relevance_score': '0.918141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",Neutral,0.116867,JNJ
Peerage Realty Partners Welcomes New CEO,"TORONTO, April 02, 2025 ( GLOBE NEWSWIRE ) -- Peerage Realty Partners, the prominent leader in luxury residential real estate markets across North America, welcomes Tara Brown to her new role as CEO, Peerage Realty Partners.",Benzinga,20250402T185146,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",Bullish,0.415805,JNJ
"Will Johnson & Johnson Rally? The Sell-Off May Have Ended - Intra-Cellular Therapies  ( NASDAQ:ITCI ) , Johnson & Johnson  ( NYSE:JNJ ) ","Shares of Johnson & Johnson suffered a significant selloff yesterday The stock found support at a level that had been resistance. Learn how to trade volatility during Q1 earnings season, live with Matt Maley on Wednesday, April 2 at 6 PM ET. Register for free now.",Benzinga,20250402T162656,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}]",Neutral,0.073229,JNJ
Why Investors Need to Take Advantage of These 2 Medical Stocks Now,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,Zacks Commentary,20250402T125008,"[{'topic': 'Earnings', 'relevance_score': '0.999682'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",Bullish,0.360791,JNJ
2 Unstoppable Stocks That Could Grow More Than 200% in 10 Years,"Netflix ( NASDAQ: NFLX ) and Intuitive Surgical ( NASDAQ: ISRG ) are leaders in their respective industries, and have produced market-beating returns over long periods. Some might argue that the best is in the rearview mirror for these corporations, considering how well they've performed in the ...",Motley Fool,20250402T094500,"[{'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",Somewhat-Bullish,0.254959,JNJ
"Stock Market News For Apr 2, 2025",Wall Street closed mixed on Tuesday to finish the first trading day of second-quarter 2025 after a choppy session.,Zacks Commentary,20250402T081900,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",Neutral,-0.009701,JNJ
"NMAX, WTF, JNJ, HIMS, TSLA: Top 5 Trending Stocks Today - Hims & Hers Health  ( NYSE:HIMS ) , Johnson & Johnson  ( NYSE:JNJ ) ","U.S. stocks closed higher on Tuesday, with the Nasdaq Composite climbing 0.9% to 17,449.89. The S&P 500 added nearly 0.4%, finishing at 5,633.07, while the Dow edged down 0.03% to 41,989.96. Market optimism was supported by a 0.7% rise in U.S. construction spending for February.",Benzinga,20250402T022727,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",Neutral,0.082659,JNJ
Why Johnson & Johnson Stock Is Sinking Today,"Shares of Johnson & Johnson ( NYSE: JNJ ) are tumbling on Tuesday. The company's stock lost 6.3% as of 2:25 p.m. ET. The drop comes as the S&P 500 and Nasdaq Composite were down 0.4% and 0.1%, respectively.The healthcare giant was rebuffed by a judge in its latest attempt to settle its yearslong ...",Motley Fool,20250401T183812,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",Somewhat-Bearish,-0.274999,JNJ
"Wall Street Inches Up Ahead Of Tariff Day, Tesla Rallies, J&J Tumbles: What's Driving Markets Tuesday? - American Airlines Group  ( NASDAQ:AAL ) ","Wall Street treaded cautiously as Trump's sweeping 20% import tariff plan loomed over $3 trillion in annual goods. Goods producers front-loaded orders, lifting inventories and driving input costs to a three-year high, survey data showed. The 'Trade of the Day' is now live.",Benzinga,20250401T172747,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",Neutral,0.06306,JNJ
Can Johnson & Johnson  ( JNJ )  Keep the Earnings Surprise Streak Alive?,Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,Zacks Commentary,20250401T161011,"[{'topic': 'Earnings', 'relevance_score': '0.999953'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",Somewhat-Bullish,0.333937,JNJ
US Judge Rejects Another Johnson & Johnson Attempt To Use Bankruptcy For Talc Cancer Claims - Johnson & Johnson  ( NYSE:JNJ ) ,"A U.S. bankruptcy court rejected J&J subsidiary Red River Talc's prepackaged bankruptcy plan. J&J will litigate talc lawsuits instead of settling, reversing $7 billion in legal reserves and challenging plaintiff claims in court.",Benzinga,20250401T135117,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",Somewhat-Bearish,-0.221286,JNJ
"This Recession-Proof Stock Soared Through the Dot-Com Bust, the Financial Crisis, and the 2022 Inflation Spike. Is It a No-Brainer Buy for the Trump Tariff Era?","President Donald Trump has barely been in office for two months, but his policies and proposals have already rocked the stock market.The S&P 500 slipped into a brief correction in March, and the Nasdaq Composite remains there today.",Motley Fool,20250401T134500,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999612'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",Neutral,0.072983,JNJ
J&J's Third Bankruptcy Attempt to End Talc Suits Rejected,J&J fails in its third attempt to settle tens of thousands of lawsuits claiming its talc-based powder caused cancer.,Zacks Commentary,20250401T133000,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",Neutral,-0.113917,JNJ
